Industry: Pharmaceuticals, Biotechnology
Viron Therapeutics Inc. is a clinical stage biopharmaceutical company focused upon the commercialization of novel anti-inflammatory therapeutics. The company is based upon the vision of the founding scientists, Grant McFadden, Ph.D. and Alexandra Lucas, M.D., who have extensive expertise in viral pathogenesis and interventional cardiology, respectively, and who have been instrumental in the development of the drug candidates for over a decade. Viron is focused on the development of therapeutics derived from viral proteins as a sustainable and unexploited source of novel ( www.vironinc.com )
Viron Therapeutics Inc.
100 Collip Circle Suite 103
London, Ontario N6G 4X8
Canada
Tel: (519) 858-5109
Fax: (519) 858-5103